Are Dr Agarwal's Eye latest results good or bad?
Dr Agarwal's Eye Hospital reported strong financial results for Q1 2025, with net sales up 23.67% to Rs 99.83 crore and a 25% increase in profit after tax to Rs 15.99 crore, indicating positive operational performance despite rising interest costs.
Dr Agarwal's Eye Hospital has reported its financial results for the quarter ending March 2025, highlighting a positive operational performance. The company achieved net sales of Rs 99.83 crore, reflecting a year-on-year growth of 23.67%, which suggests a robust near-term outlook. Operating profit, or PBDIT, reached Rs 31.59 crore, marking the highest level in the last five quarters, with an operating profit margin of 31.64%. This indicates an enhancement in operational efficiency. The profit before tax (PBT) was reported at Rs 18.50 crore, showing a year-on-year growth of 24.33%, while profit after tax (PAT) reached Rs 15.99 crore, reflecting a 25% increase compared to the previous year.
Earnings per share (EPS) also reached Rs 34.02, the highest in five quarters, which points to improved profitability for shareholders. However, the company experienced rising interest costs, with interest expenses increasing by 51.09% over the preceding nine months due to higher borrowings.
Overall, Dr Agarwal's Eye Hospital has demonstrated strong financial performance in the latest quarter, and the company saw an adjustment in its evaluation based on these results.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
